Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis

doi:10.12998/wjcc.v11.i30.7337

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2228)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

105

WORD

HTML

1148

Figures (1-5)

236

Tables (1-3)

222

Sum=1735

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

138

Download

291

Sum=429

Oct 26, 2023 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Oct 26, 2023; 11(30): 7337-7349
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7337

Full Size Figure Download Figure

Figure 5 Forest plot comparing the effect of bevacizumab with placebo on the risk of developing an epithelial defect.

Citation: Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349
URL: https://www.wjgnet.com/2307-8960/full/v11/i30/7337.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i30.7337